Biodesix Stock Buy Hold or Sell Recommendation
| BDSX Stock | USD 1.43 0.01 0.69% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Biodesix is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Biodesix given historical horizon and risk tolerance towards Biodesix. When Macroaxis issues a 'buy' or 'sell' recommendation for Biodesix, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Biodesix Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide. In addition, we conduct extensive research on individual companies such as Biodesix and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Biodesix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Biodesix |
Execute Biodesix Buy or Sell Advice
The Biodesix recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Biodesix. Macroaxis does not own or have any residual interests in Biodesix or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Biodesix's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Biodesix Trading Alerts and Improvement Suggestions
| Biodesix generated a negative expected return over the last 90 days | |
| Biodesix may become a speculative penny stock | |
| Biodesix has high historical volatility and very poor performance | |
| Biodesix has a very high chance of going through financial distress in the upcoming years | |
| Biodesix currently holds 60.69 M in liabilities with Debt to Equity (D/E) ratio of 3.2, implying the company greatly relies on financing operations through barrowing. Biodesix has a current ratio of 0.63, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Biodesix's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 49.09 M. Net Loss for the year was (52.15 M) with profit before overhead, payroll, taxes, and interest of 24.06 M. | |
| Biodesix currently holds about 15.18 M in cash with (22.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| Biodesix has a poor financial position based on the latest SEC disclosures | |
| Roughly 49.0% of Biodesix shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Disposition of 2781 shares by Scott Hutton of Biodesix at 1.601 subject to Rule 16b-3 |
Biodesix Returns Distribution Density
The distribution of Biodesix's historical returns is an attempt to chart the uncertainty of Biodesix's future price movements. The chart of the probability distribution of Biodesix daily returns describes the distribution of returns around its average expected value. We use Biodesix price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Biodesix returns is essential to provide solid investment advice for Biodesix.
| Mean Return | -0.29 | Value At Risk | -5.61 | Potential Upside | 5.95 | Standard Deviation | 4.35 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Biodesix historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Biodesix Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Biodesix, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Biodesix back and forth among themselves.
| Shares | Lmr Partners Llp | 2024-06-30 | 1.6 M | Essex Investment Management Company, Llc | 2024-09-30 | 971.2 K | Wells Fargo & Co | 2024-06-30 | 931.2 K | Geode Capital Management, Llc | 2024-09-30 | 804.6 K | Perkins Capital Management Inc | 2024-09-30 | 724.8 K | Amh Equity Ltd | 2024-09-30 | 696.1 K | Blackrock Inc | 2024-06-30 | 415.9 K | Legato Capital Management Llc | 2024-09-30 | 334.3 K | State Street Corp | 2024-06-30 | 288.6 K | Telemark Asset Management, Llc | 2024-09-30 | 8.3 M | Soleus Capital Management, L.p. | 2024-06-30 | 6.1 M |
Biodesix Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 17K | (11.7M) | 7.4M | 906K | 166K | 174.3K | |
| Investments | (1.9M) | (2.9M) | (2.5M) | (3.5M) | (22.0M) | (20.9M) | |
| Change In Cash | (626K) | 56.8M | (29.5M) | 10.4M | (16.8M) | (16.0M) | |
| Net Borrowings | 13.0M | 16.0M | (15.5M) | 16.5M | 14.8M | 15.6M | |
| Free Cash Flow | (23.1M) | (23.5M) | (30.8M) | (48.5M) | (45.9M) | (48.2M) | |
| Depreciation | 2.8M | 2.9M | 3.2M | 5.8M | 5.5M | 4.0M | |
| Other Non Cash Items | 5.3M | 6.6M | 4.3M | 13.0M | 7.1M | 7.8M | |
| Capital Expenditures | 1.4M | 2.2M | 2.5M | 3.5M | 23.1M | 24.2M | |
| Net Income | (30.7M) | (31.4M) | (43.2M) | (65.4M) | (52.1M) | (54.8M) | |
| End Period Cash Flow | 5.5M | 62.3M | 32.8M | 43.2M | 26.4M | 32.3M | |
| Change To Netincome | 7.4M | 7.3M | 7.2M | 19.0M | 21.8M | 22.9M |
Biodesix Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Biodesix or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Biodesix's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Biodesix stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.29 | |
β | Beta against Dow Jones | -0.07 | |
σ | Overall volatility | 4.33 | |
Ir | Information ratio | -0.09 |
Biodesix Volatility Alert
Biodesix exhibits very low volatility with skewness of -2.42 and kurtosis of 12.22. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Biodesix's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Biodesix's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Biodesix Fundamentals Vs Peers
Comparing Biodesix's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Biodesix's direct or indirect competition across all of the common fundamentals between Biodesix and the related equities. This way, we can detect undervalued stocks with similar characteristics as Biodesix or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Biodesix's fundamental indicators could also be used in its relative valuation, which is a method of valuing Biodesix by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Biodesix to competition |
| Fundamentals | Biodesix | Peer Average |
| Return On Equity | -3.32 | -0.31 |
| Return On Asset | -0.23 | -0.14 |
| Profit Margin | (0.67) % | (1.27) % |
| Operating Margin | (0.47) % | (5.51) % |
| Current Valuation | 237.84 M | 16.62 B |
| Shares Outstanding | 145.47 M | 571.82 M |
| Shares Owned By Insiders | 48.61 % | 10.09 % |
| Shares Owned By Institutions | 42.82 % | 39.21 % |
| Number Of Shares Shorted | 388.86 K | 4.71 M |
| Price To Book | 7.44 X | 9.51 X |
| Price To Sales | 3.16 X | 11.42 X |
| Revenue | 49.09 M | 9.43 B |
| Gross Profit | 24.06 M | 27.38 B |
| EBITDA | (37.1 M) | 3.9 B |
| Net Income | (52.15 M) | 570.98 M |
| Cash And Equivalents | 15.18 M | 2.7 B |
| Cash Per Share | 0.36 X | 5.01 X |
| Total Debt | 60.69 M | 5.32 B |
| Debt To Equity | 3.20 % | 48.70 % |
| Current Ratio | 0.64 X | 2.16 X |
| Book Value Per Share | 0.19 X | 1.93 K |
| Cash Flow From Operations | (22.87 M) | 971.22 M |
| Short Ratio | 1.13 X | 4.00 X |
| Earnings Per Share | (0.37) X | 3.12 X |
| Target Price | 3.1 | |
| Number Of Employees | 217 | 18.84 K |
| Beta | 1.21 | -0.15 |
| Market Capitalization | 207.29 M | 19.03 B |
| Total Asset | 99.1 M | 29.47 B |
| Retained Earnings | (419.57 M) | 9.33 B |
| Working Capital | 6.27 M | 1.48 B |
| Net Asset | 99.1 M |
Note: Disposition of 2781 shares by Scott Hutton of Biodesix at 1.601 subject to Rule 16b-3 [view details]
Biodesix Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Biodesix . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Biodesix Buy or Sell Advice
When is the right time to buy or sell Biodesix? Buying financial instruments such as Biodesix Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Biodesix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Biotech Thematic Idea Now
Biotech
Companies specialized in biotechnology production and delivery of pharmaceuticals services. The Biotech theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Biotech Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Biodesix Stock Analysis
When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.